Egypt - English - EDA (Egyptian Drug Authority)

eipico-egypt - injection - 20 mg/2ml

New Zealand - English - Medsafe (Medicines Safety Authority)

reckitt benckiser (new zealand) limited - benzalkonium chloride 4%{vol} (added as 7.84% w/w empigen bac 50 =4%v/v benzalk.chloride) - antiseptic solution - 4 % - active: benzalkonium chloride 4%{vol} (added as 7.84% w/w empigen bac 50 =4%v/v benzalk.chloride) excipient: disodium edetate dihydrate isopropyl alcohol citropine propylene glycol water

Australia - English - Department of Health (Therapeutic Goods Administration)

epigenhealth pty ltd - pinus pinaster, quantity: 5.78 mg/ml (equivalent: pinus pinaster, qty 5.78 g/ml; equivalent: procyanidins (of pinus pinaster), qty 3.87 mg/ml) - oral liquid - excipient ingredients: sodium benzoate; purified water; potassium sorbate; glycerol; steviol glycosides; acetic acid; sodium chloride; xanthan gum; flavour - antioxidant/reduce free radicals formed in the body ; helps enhance/promote general health and wellbeing

Australia - English - Department of Health (Therapeutic Goods Administration)

epigenhealth pty ltd - pinus pinaster, quantity: 5.78 mg/ml (equivalent: pinus pinaster, qty 5.78 g/ml; equivalent: procyanidins (of pinus pinaster), qty 3.87 mg/ml) - oral liquid - excipient ingredients: sodium benzoate; purified water; potassium sorbate; glycerol; steviol glycosides; acetic acid; sodium chloride; xanthan gum; flavour - antioxidant/reduce free radicals formed in the body ; helps enhance/promote general health and wellbeing

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - selenium disulfide - shampoo - 2.5 percent weight/volume - medicated shampoos; selenium compounds

Ireland - English - HPRA (Health Products Regulatory Authority)

opella healthcare france sas t/a sanofi - selenium disulfide - shampoo - 2.5 percent weight/volume - medicated shampoos; selenium compounds

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 1000 iu/vial - antihemophilic factor (recombinant) sucrose formulated 1000 iu/vial

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 250iu/vial - antihemophilic factor (recombinant) sucrose formulated 250iu/vial

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 500iu/vial - antihemophilic factor (recombinant) sucrose formulated 500iu/vial

European Union - English - EMA (European Medicines Agency)

bayer ag  - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor-viii deficiency).this preparation does not contain von willebrand factor and is therefore not indicated in von willebrand's disease.